High drug development costs from increasingly complex products have pushed pharma companies to accelerate timelines as much as possible, creating a “race to market” of sorts. But scaling up too quickly has its risks — risks that the right CDMO partner can help mitigate.
Watch Thermo Fisher Scientific’s on-demand webinar, “Navigating a smarter race to market for oral solid-dose products” to learn:
- How to design a development and manufacturing strategy that utilizes quality by design (QbD) principles, digital modeling, and other best practices
- Opportunities to engage a multidisciplinary approach across formulation development, process engineering, analytical sciences, and regulatory affairs
- How an industry-leading, global CDMO partner can benefit programs of any scope or scale — including programs of single-molecule, emerging startups